GB0708691D0 - Anticancer treatments a - Google Patents

Anticancer treatments a

Info

Publication number
GB0708691D0
GB0708691D0 GBGB0708691.1A GB0708691A GB0708691D0 GB 0708691 D0 GB0708691 D0 GB 0708691D0 GB 0708691 A GB0708691 A GB 0708691A GB 0708691 D0 GB0708691 D0 GB 0708691D0
Authority
GB
United Kingdom
Prior art keywords
anticancer treatments
anticancer
treatments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0708691.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmamar SA
Original Assignee
Pharmamar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmamar SA filed Critical Pharmamar SA
Priority to GBGB0708691.1A priority Critical patent/GB0708691D0/en
Publication of GB0708691D0 publication Critical patent/GB0708691D0/en
Priority to PCT/GB2008/050330 priority patent/WO2008135792A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995Pyrazines or piperazines forming part of bridged ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
GBGB0708691.1A 2007-05-04 2007-05-04 Anticancer treatments a Ceased GB0708691D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0708691.1A GB0708691D0 (en) 2007-05-04 2007-05-04 Anticancer treatments a
PCT/GB2008/050330 WO2008135792A1 (en) 2007-05-04 2008-05-06 Pm00104 compound for use in cancer therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0708691.1A GB0708691D0 (en) 2007-05-04 2007-05-04 Anticancer treatments a

Publications (1)

Publication Number Publication Date
GB0708691D0 true GB0708691D0 (en) 2007-06-13

Family

ID=38198780

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0708691.1A Ceased GB0708691D0 (en) 2007-05-04 2007-05-04 Anticancer treatments a

Country Status (2)

Country Link
GB (1) GB0708691D0 (en)
WO (1) WO2008135792A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009248039B2 (en) * 2008-05-16 2014-07-31 Pharma Mar, S.A. Multiple myeloma treatments
WO2011048210A1 (en) 2009-10-22 2011-04-28 Pharma Mar, S.A. PDGFR-α AS RESPONSE MARKER FOR PM00104 TREATMENT

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY130271A (en) * 1999-05-14 2007-06-29 Pharma Mar Sa Hemisynthetic method and new compounds
GB0522082D0 (en) * 2005-10-31 2005-12-07 Pharma Mar Sa Formulations

Also Published As

Publication number Publication date
WO2008135792A1 (en) 2008-11-13

Similar Documents

Publication Publication Date Title
EP2329632A4 (en) Hiding a device identity
EP2340752A4 (en) A bread-toaster
PL2148561T3 (en) A planter
AP2010005191A0 (en) A structure
GB0908606D0 (en) A stereo-endoscope
ZA201103616B (en) A relief valve
GB0719518D0 (en) Therapy
GB0922260D0 (en) A pipe-liner
GB0821985D0 (en) A gear
GB0725221D0 (en) A footstool
IL208001A0 (en) Improved anticancer treatments
EP2358251A4 (en) A dustcup
GB0708691D0 (en) Anticancer treatments a
GB0719788D0 (en) A retaining arrangement
GB2458284B (en) A button-cuff
EP2105140A4 (en) Anticancer agent
GB0820625D0 (en) A medicament
PL2237716T3 (en) A diswasher
GB0808288D0 (en) A different windturbine
GB0708693D0 (en) Anticancer treatments
GB0710043D0 (en) Anticancer treatments
GB0716072D0 (en) Therapy
GB0700635D0 (en) Therapy
GB0719860D0 (en) A combination therapy
GB0705557D0 (en) A treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)